Bharat Immunologicals & Biologicals (BOM:524663) Margin of Safety % (DCF FCF Based) : N/A (As of May. 28, 2024)

View and export this data going back to 2000. Start your Free Trial

What is Bharat Immunologicals & Biologicals Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Bharat Immunologicals & Biologicals's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

Competitive Comparison of Bharat Immunologicals & Biologicals's Margin of Safety % (DCF FCF Based)

For the Biotechnology subindustry, Bharat Immunologicals & Biologicals's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bharat Immunologicals & Biologicals's Margin of Safety % (DCF FCF Based) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bharat Immunologicals & Biologicals's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Bharat Immunologicals & Biologicals's Margin of Safety % (DCF FCF Based) falls into.

Bharat Immunologicals & Biologicals Margin of Safety % (DCF FCF Based) Related Terms

Thank you for viewing the detailed overview of Bharat Immunologicals & Biologicals's Margin of Safety % (DCF FCF Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Bharat Immunologicals & Biologicals (BOM:524663) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bharat Immunologicals & Biologicals Corp Ltd (BOM:524663) » Definitions » Margin of Safety % (DCF FCF Based)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Village Chola, BIBCOL, OPV Plant, Bulandshahar, UP, IND, 203203

Website

http://www.bibcol.sciencecentral.in

Bharat Immunologicals & Biologicals Corp Ltd is an India-based biotechnology company. It primarily manufactures Oral polio vaccines. In addition, the company also manufactures zinc tablets, diarrhea management kits, and Ready to Use Therapeutic Food (RUTF). It also manufactures nutraceuticals and biological products for the treatment of health deficiencies and disorders. The firm is organized into three segments: Oral Polio Vaccine, Zinc Tablets, and BIB VIT, BIBSANIT. The group principally operates in India and generates the majority of its revenue from sales of Oral polio vaccines.

Bharat Immunologicals & Biologicals (BOM:524663) Headlines

No Headlines